Zhejiang Ausun Pharmaceutical Hits Day Low of CNY 8.63 Amid Price Pressure

Zhejiang Ausun Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 5.32% and reaching an intraday low of CNY 8.63. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Zhejiang Ausun has seen a cumulative decline of 9.64%, while its monthly performance reflects a decrease of 9.17%. Year-to-date, the stock has underperformed with a loss of 12.1%, compared to the China Shanghai Composite's decline of 3.92%. The three-year performance shows a stark drop of 63.39%, and over five years, the stock has plummeted by 77.41%. Financial metrics indicate challenges for the company, with net sales for the latest quarter falling by 16.2% to CNY 164.09 million and a net profit decline of 23.85% to CNY 88.54 million. The return on equity stands at 7.65%, and the price-to-book ratio is at 3.40, suggesting a relatively high valuation in the current market context. Overall, Zhejiang Ausun's recent performance highlights a notable divergence from market trends and raises questions about its financial health.